Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioline D Henter

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Advances in Pharmacology (San Diego, Calif.)|July 4, 2020
Neurobiological biomarkers of response to ketamineBashkim Kadriu, Elizabeth D Ballard, Ioline D Henter, et al.
The Journal of Clinical Psychiatry|May 28, 2020
Not So Fast: Recent Successes and Failures in Treating DepressionBashkim Kadriu, Zhi-De Deng, Christoph Kraus, et al.
The Journal of Clinical Psychiatry|May 25, 2010
The neurobiology of the switch process in bipolar disorder: a reviewGiacomo Salvadore, Jorge A Quiroz, Rodrigo Machado-Vieira, et al.
The Lancet. Neurology|October 25, 2020
PET imaging of neuroinflammation in neurological disordersWilliam C Kreisl, Min-Jeong Kim, Jennifer M Coughlin, et al.
The International Journal of Neuropsychopharmacology|November 30, 2020
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting AntidepressantsBashkim Kadriu, Maximillian Greenwald, Ioline D Henter, et al.
The International Journal of Neuropsychopharmacology|December 5, 2021
Suicide Biomarkers to Predict Risk, Classify Diagnostic Subtypes, and Identify Novel Therapeutic Targets: 5 Years of Promising ResearchJenessa N Johnston, Darcy Campbell, Hector J Caruncho, et al.
The Lancet. Psychiatry|October 25, 2020
Neuroinflammation in psychiatric disorders: PET imaging and promising new targetsJeffrey H Meyer, Simon Cervenka, Min-Jeong Kim, et al.
Trends in Pharmacological Sciences|March 10, 2009
Animal models of suicide-trait-related behaviorsOz Malkesman, Daniel S Pine, Tyson Tragon, et al.
Behaviour Research and Therapy|August 15, 2017
Altered interaction with environmental reinforcers in major depressive disorder: Relationship to anhedoniaJoanna E Szczepanik, Maura L Furey, Allison C Nugent, et al.
Expert Review of Clinical Pharmacology|October 27, 2016
Mood Therapeutics: Novel Pharmacological Approaches for Treating DepressionIoline D Henter, Rafael T de Sousa, Philip W Gold, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Advances in Pharmacology (San Diego, Calif.)|July 4, 2020
Neurobiological biomarkers of response to ketamineBashkim Kadriu, Elizabeth D Ballard, Ioline D Henter, et al.
The Journal of Clinical Psychiatry|May 28, 2020
Not So Fast: Recent Successes and Failures in Treating DepressionBashkim Kadriu, Zhi-De Deng, Christoph Kraus, et al.
The Journal of Clinical Psychiatry|May 25, 2010
The neurobiology of the switch process in bipolar disorder: a reviewGiacomo Salvadore, Jorge A Quiroz, Rodrigo Machado-Vieira, et al.
The Lancet. Neurology|October 25, 2020
PET imaging of neuroinflammation in neurological disordersWilliam C Kreisl, Min-Jeong Kim, Jennifer M Coughlin, et al.
The International Journal of Neuropsychopharmacology|November 30, 2020
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting AntidepressantsBashkim Kadriu, Maximillian Greenwald, Ioline D Henter, et al.
The International Journal of Neuropsychopharmacology|December 5, 2021
Suicide Biomarkers to Predict Risk, Classify Diagnostic Subtypes, and Identify Novel Therapeutic Targets: 5 Years of Promising ResearchJenessa N Johnston, Darcy Campbell, Hector J Caruncho, et al.
The Lancet. Psychiatry|October 25, 2020
Neuroinflammation in psychiatric disorders: PET imaging and promising new targetsJeffrey H Meyer, Simon Cervenka, Min-Jeong Kim, et al.
Trends in Pharmacological Sciences|March 10, 2009
Animal models of suicide-trait-related behaviorsOz Malkesman, Daniel S Pine, Tyson Tragon, et al.
Behaviour Research and Therapy|August 15, 2017
Altered interaction with environmental reinforcers in major depressive disorder: Relationship to anhedoniaJoanna E Szczepanik, Maura L Furey, Allison C Nugent, et al.
Expert Review of Clinical Pharmacology|October 27, 2016
Mood Therapeutics: Novel Pharmacological Approaches for Treating DepressionIoline D Henter, Rafael T de Sousa, Philip W Gold, et al.
Pageof 8